Table: 2.
Description of included studies in the review.
| S.N | Authors with citation | Publication year | country | Mean age | Sample size | Design | Intervention modality (prevention or treatment) | Main findings | ROB |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Moghadam A et al. [18] | 2013 | Iran | 26.5 | 102 | RCT | Effect of acupressure on postoperative nausea and vomiting in cesarean section | Acupressure was shown to be effective for reducing nausea and vomiting. | Low |
| 2 | H.Noroozinia et al. [19] | 2013 | Iran | 152 | RCT | The Effect of Acupressure on Nausea and Vomiting after Cesarean Section Under Spinal Anesthesia | Acupressure when done 30 min before surgery effectively reduces postoperative nausea and vomiting, | Low | |
| 3 | M.El-Deeb et al. [20] | 2011 | Egypt | 30 | 450 | RCT | Effect of acupuncture on nausea and/or vomiting during and after cesarean section in comparison with ondansetron | Acupuncture has comparable effectiveness with a single dose of 4 mg ondansetron in PONV prevention and is cost-effective. | Low |
| 4 | Pakniat H et al. [21] | 2020 | Iran | 29 | 180 | RCT | The effect of ginger and metoclopramide in the prevention of nausea and vomiting during and after surgery in the cesarean section under spinal anesthesia. | Ginger has the same effectiveness as metoclopramide in reducing nausea and vomiting in patients undergoing cesarean section. | Low |
| 5 | Zeraati H et al. [22] | 2016 | Iran | 30 | 92 | RCT | The effect of ginger extract on the incidence and severity of nausea and vomiting after cesarean section under spinal anesthesia. | Ginger extract can be used to reduce nausea and vomiting during cesarean section under spinal anesthesia. | Low |
| 6 | Kalava A et al. [23] | 2013 | USA | 239 | RCT, | Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. | Ginger has no effect on the overall occurrence of intraoperative nausea and vomiting during cesarean section done under CSE anesthesia | High | |
| 7 | Rasooli S et al. [24] | 2019 | Iran | 29 | 110 | RCT | Preventing nausea and vomiting using ondansetron and metoclopramide-phenylephrine in cesarean section using spinal anesthesia. | The combination of prophylactic therapy with metoclopramide and ondansetron can significantly reduce intra and PON in patients undergoing CS under spinal anesthesia. | Low |
| 8 | Voigt M et al. [25] | 2013 | Germany | >18 | 308 | RCT, | Prophylaxis of intra-and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. | tropisetron 2 mg and metoclopramide 20 mg Prophylaxis for patients undergoing cesarean section decreases the incidence of nausea and vomiting | Low |
| 9 | Rasheed MA et al. [26] | 2019 | India | 26 | 120 | RCT, | Evaluation of Efficacy of Metoclopramide, Dexamethasone and Their Combination for the Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Cesarean Section. | Prophylactic administration of a combination of dexamethasone and metoclopramide was significantly superior for the prevention of PONV than the use of dexamethasone and metoclopramide alone. | Low |
| 10 | Modir H et al. [27] | 2019 | Iran | 26 | 140 | RCT, | Prophylactic efficacy of dexamethasone, ketamine, and Dexmedetomidine against intra-and postoperative nausea and vomiting under spinal anesthesia. | Dexmedetomidine has a greater effect in reducing nausea and vomiting. Although All three medications could reduce nausea and vomiting in patients. low | Low |
| 11 | Endalew ES et al. [28] | 2018 | Ethiopia | > | 132 | Prospective non-controlled, | Effectiveness of intravenous metoclopramide prophylaxis on the reduction of intraoperative and early postoperative nausea and vomiting after emergency cesarean section under spinal anesthesia. | metoclopramide Prophylaxis reduces the incidence and severity of intraoperative and early PONV compared to the non-treatment group | Low |
| 12 | Patel PC. et al. [29] | 2021 | India | 30 | 90 | Cross-sectional | Comparison of injection granisetron versus injection ondansetron for control of IONV and PONV among the women undergoing lower segment cesarean section under spinal anesthesia. | 2 mg IV Granisetron is better in preventing intraoperative as well as PONV as compared to 4 mg IV ondansetron. | Low |
| 13 | Dasgupta M et al. [30] | 2012 | India | 28.5 | 80 | RCT, | Randomized, placebo-controlled trial of granisetron for control of nausea and vomiting during cesarean delivery under spinal anesthesia. | use of granisetron Prophylaxis is effective for preventing vomiting episodes during spinal anesthesia for cesarean section |
Low |
| 14 | Chattopadhyay S et al. [31] | 2015 | Indian | 26.5 | 109 | RCT, | Palonosetron versus ramosetron prophylaxis for control of postoperative nausea and vomiting after cesarean delivery under spinal anesthesia. | Polanosetron Prophylaxis is more effective than ramosetron prophylaxis for the long-term prevention of PONV after cesarean section. | Low |
| 15 | Kampo S et al. [32], | 2019 | Ghana | 30 | 345 | RCT | Sub-hypnotic dose of Propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section | sub-hypnotic dose of Propofol has the same effectiveness as metoclopramide in the prevention of PONV in women undergoing cesarean section under spinal anesthesia with adjunct intrathecal morphine | Low |
| 16 | Abdalla E et al. [33] | 2019 | Egypt | 120 | RCT | Intravenous dexamethasone combined with intrathecal atropine to prevent morphine-related nausea and vomiting after cesarean delivery. | Combination of IV dexamethasone and intrathecal atropine has additive antiemetic effect after SA for CS using bupivacaine and morphine | low | |
| 17 | Jabalameli M et al. [8] | 2012 | Iran | 31.5 | 132 | RCT | Treatment of postoperative nausea and vomiting after spinal anesthesia for cesarean delivery: comparison of midazolam, ondansetron, and a combination. | IV 30 μg/kg midazolam in combination with IV 8 mg ondansetron was superior to administering a single drug for the treatment of emetic symptoms after CS under SA. | Low |